Literature DB >> 17532051

The responsiveness of EQ-5D utility scores in patients with depression: A comparison with instruments measuring quality of life, psychopathology and social functioning.

Oliver H Günther1, Christiane Roick, Matthias C Angermeyer, Hans-Helmut König.   

Abstract

INTRODUCTION: The EQ-5D provides preference weights (utilities) for health-related quality of life to be used for calculating quality-adjusted life years (QALYs) in cost-utility analysis. The aim of this study was to compare differences in EQ-5D utility scores with differences in quality of life, psychopathology, and social functioning scores.
METHODS: In an observational longitudinal cohort study, EQ-5D utilities (EQ visual analogue scale (EQ VAS), EQ-5D indices of the United Kingdom (EQ-5D index-UK) and Germany (EQ-5D index-D)) were compared with scores of the WHOQOL-BREF, CGI, and GAF at baseline and at 18 months (N=104). The patients' health status at follow-up was categorized as "worse", "stable", or "better" using the EQ-5D transition question (patient-based anchor) and the Bech-Rafaelsen melancholy scale (clinician-based anchor). Effect sizes (ES) were used to compare differences in scores within each group over time; regression analysis was used to derive meaningful difference scores in health status associated with a shift from "stable" to "better" health status.
RESULTS: The most responsive instrument was the CGI (patient-based anchor: ES=|0.98|; clinician-based anchor: ES=|1.35|); responsiveness was large in EQ VAS (patient-based anchor: ES=|0.84|; clinician-based anchor: ES=|1.19|), but rather small to medium for EQ-5D index-UK (patient-based anchor: ES=|0.55|; clinician-based anchor: ES=|0.65|) and EQ-5D index-D (patient-based anchor: ES=|0.41|; clinician-based anchor: ES=|0.45|). Compared with the other instruments, the shift to a "better health status" was smaller if elicited by the EQ-5D indices. DISCUSSION: Both EQ-5D indices were less responsive and need larger patient samples to detect meaningful differences compared with EQ VAS and the other instruments.

Entities:  

Mesh:

Year:  2007        PMID: 17532051     DOI: 10.1016/j.jad.2007.04.018

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  20 in total

1.  Using the EuroQol EQ-5D in Swiss cancer patients, which value set should be applied?

Authors:  Klazien Matter-Walstra; Dirk Klingbiel; Thomas Szucs; Bernhard C Pestalozzi; Matthias Schwenkglenks
Journal:  Pharmacoeconomics       Date:  2014-06       Impact factor: 4.981

2.  Evidence on the longitudinal construct validity of major generic and utility measures of health-related quality of life in teens with depression.

Authors:  John F Dickerson; David H Feeny; Gregory N Clarke; Alex L MacMillan; Frances L Lynch
Journal:  Qual Life Res       Date:  2017-11-17       Impact factor: 4.147

Review 3.  EQ-5D in Central and Eastern Europe: 2000-2015.

Authors:  Fanni Rencz; László Gulácsi; Michael Drummond; Dominik Golicki; Valentina Prevolnik Rupel; Judit Simon; Elly A Stolk; Valentin Brodszky; Petra Baji; Jakub Závada; Guenka Petrova; Alexandru Rotar; Márta Péntek
Journal:  Qual Life Res       Date:  2016-07-29       Impact factor: 4.147

4.  Home-based, peer-led chronic illness self-management training: findings from a 1-year randomized controlled trial.

Authors:  Anthony Jerant; Monique Moore-Hill; Peter Franks
Journal:  Ann Fam Med       Date:  2009 Jul-Aug       Impact factor: 5.166

5.  Validity and responsiveness of the EQ-5D in assessing and valuing health status in patients with anxiety disorders.

Authors:  Hans-Helmut König; Anja Born; Oliver Günther; Herbert Matschinger; Sven Heinrich; Steffi G Riedel-Heller; Matthias C Angermeyer; Christiane Roick
Journal:  Health Qual Life Outcomes       Date:  2010-05-05       Impact factor: 3.186

Review 6.  The importance of functional impairment to mental health outcomes: a case for reassessing our goals in depression treatment research.

Authors:  Patrick E McKnight; Todd B Kashdan
Journal:  Clin Psychol Rev       Date:  2009-02-07

7.  Psychometric evaluation of the WHOQOL-BREF in community-dwelling older people in Taiwan using Rasch analysis.

Authors:  Wen-Miin Liang; Chih-Hung Chang; Yi-Chun Yeh; Haw-Yaw Shy; Hung-Wei Chen; Mau-Roung Lin
Journal:  Qual Life Res       Date:  2009-04-02       Impact factor: 4.147

8.  Personality and EQ-5D scores among individuals with chronic conditions.

Authors:  Anthony Jerant; Benjamin P Chapman; Peter Franks
Journal:  Qual Life Res       Date:  2008-10-07       Impact factor: 4.147

9.  Putting the 'Q' in depression QALYs: a comparison of utility measurement using EQ-5D and SF-6D health related quality of life measures.

Authors:  Rachel Mann; Simon Gilbody; David Richards
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-11-13       Impact factor: 4.328

10.  Utility assessment in patients with mental disorders: validity and discriminative ability of the time trade-off method.

Authors:  Hans-Helmut König; Oliver H Günther; Matthias C Angermeyer; Christiane Roick
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.